Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Genitourinary: Yeast vaginitis, menstrual irregularities, PMS, bladder inflammation, chronic urinary tract infections (UTIs), cystitis
Semaglutide is a GLP-1 receptor agonist , meaning it mimics a hormone involved in: Appetite control Insulin regulation Slowing gastric emptying This helps reduce hunger and supports calorie control
The total milligrams of active compound entering your body is what determines effectiveness
Undeniably powerful weight loss in a pen and a pill 1-3 Along with diet and exercise Wegovy HD In adults with obesity, Efficacy estimand: ~21% (20.7%) mean weight loss with Wegovy HD (semaglutide) injection 7.2 mg vs 2.4% with placebo at 72 weeks, in an idealized scenario estimating efficacy if all patients remained on treatment and used no other weight-loss therapies* Treatment regimen estimand: ~19% (18.8%) mean weight loss with Wegovy HD vs 3.9% with placebo at 72 weeks, for all patients in the trial regardless of whether patients stayed on treatment or took other weight-loss therapies For adults taking Wegovy for weight reduction: Those who tolerate the 2.4 mg dosage for at least 4 weeks and additional weight reduction is clinically indicated, the dosage may be increased to a maximum dosage of 7.2 mg subcutaneously once weekly
